Summary.-The determination of hormone inducible proteins in endocrine tumours may yield information about the presence of hormone dependent tumour cells. We have estimated the high affinity oestradiol binding capacity in primary mammary carcinomata of 57 postmenopausal patients. Glucose-6-phosphate dehydrogenase and lactose synthetase are known from animal experiments to be hormone inducible. Therefore, in biopsies of sufficient size the activity of glucose-6-phosphate dehydrogenase (47 patients) and lactose synthetase (23 patients) was also studied. It was found that biopsies with high binding capacity also showed high activities of glucose -6-phosphate dehydrogenase and lactose synthetase A protein (galactosyl transferase). No lactose synthetase B protein (a-lactalbumin) has been discovered in the tumours. The present observations may be considered suggestive evidence of a relationship between high oestradiol binding capacity and high activities of the two enzymes on the one hand and hormone dependence of the tumour on the other. However, further clinical studies are required before final conclusions in this respect can be drawn.
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THE SPECIFIC problem of developing predictive tests for hormone dependence in human mammary tumours is of considerable importance in the planning of rational endocrine therapy of this category of patients. Determination of the content of oestradiol receptors in the tumour has proved to be valuable in predicting the outcome ofendocrine ablation in mammary cancer patients , and there are indications that there is a correlation between the response to oestrogen or anti-oestrogen therapy and the content of receptor protein in the tumour (Engelsman et al., 1973) . Estimates of the amounts of various proteins known to be subject to hormonal regulation are conceivably also of value in predicting the hormone dependence of a given tumour.
From animal experiments, such pro-* Sponsored by the Danish Cancer Society.
teins are known to include the hormone inducible enzymes, glucose-6-phosphate dehydrogenase (G-6-PDH) (Bonsignore and De Flora, 1972) and lactose synthetase (LS) (Turkington et al., 1968; Palmiter, 1969) . Investigations of this type have been conducted in this laboratory using GR mouse mammary tumours (Briand and Daehnfeldt, 1973; Schulein, Daehnfeldt and Briand, 1974) . In these studies, we have reported a higher G-6-PDH activity in hormone dependent GR mouse mammary tumours compared with independent tumours. The LS A-protein activity in the same tumour system was found to be high in both dependent and independent tumours, while LS B-protein was non- (1966) showed that this contamination varied from 10 to 20%. The first 20 tumour specimens were also tested for oestradiol binding capacity using the agar gel electrophoresis method (Wagner, 1972 Glock and McLean (1953) as described by Briand and Daehnfeldt (1973) by monitoring the formation of NADPH at 340 nm in an assay volume of 1-0 ml. Results were expressed as ng/mg supernatant protein. A modification (Schiilein et al., 1974) of the radiochemical method of Brew, Vanaman and Hill (1968) wfas applied to determine LS activity. UDP-14C-galactose was used as labelled precursor. Only soluble LS A-protein was routinely determined but fractionated determinations were performed using Triton-X-100 to solubilize particle bound LS Aprotein. With the preparation technique used in this study, more than 90%o of the LS A-protein activity was recovered in the soluble fraction. LS B-protein was determined with an excess of bovine LS A-protein, prepared from cow's milk whey.
The distribution of the data obtained was not normal. Therefore, statistical evaluation was performed with the nonparametric Wilcoxon's rank test (Ciba-Geigy Scientific Tables, 1970) .
RESULTS
Determinations of the high affinity oestradiol receptor protein fall into the following two groups: Group I, in which less than 2 X 10-14 mol oestradiol is bound/mg protein (this corresponds to twice the detection limit), and Group II, in which more than 2 x 10-14 mol oestradiol is bound/mg protein.
From the (England et al., 1974) .
Taking the KD value of 2 x 10-9 mol into consideration, the experimentally determined binding capacity for oestradiol in the subgroup, showing binding capacities larger than 10 x 10-14 mol/mg p.otein, may be expected to be a good
approximation of the number of total receptor sites in postmenopausal patients. However, if any of the patients have an oestradiol concentration which approaches the normal premenopausal concentration, the experimentally determined binding capacity for oestradiol will reflect an incorrect, low content of receptor protein (Daehnfeldt, 1974) . We believe that this may have been the case in the patients with binding capacities between 2 and 10 x 10-14 mol of oestradiol bound/ mg protein.
In agreement with both Wittliff et al. (1972) and Leclerq et al. (1973) we have found no correlation between the histological classification of the tumour and the receptor content. Jensen's (1973) histochemical investigation of the G-6-PDH showed a high enzyme activity ill 480% of the human mammary carcinomata investigated. This is in agreement with our findings.
The concordance between the high binding capacity observed in the present study and high G-6-PDH activity in the human mammary tumours is in agreement with our previous findings in GR mouse mammary tumours. The development of hormone independence of these tumours is accompanied by decreased G-6-PDH activity (Briand and Daehnfeldt, 1973) and oestradiol receptor content (Terenius, 1972; Daehnfeldt, unpublished) . On the other hand, according to Hilf et al. (1973) the oestradiol binding capacity in human mammary carcinomata seems to be unrelated to the activity of G-6-PDH. The material used in Hilf's study included premenopausal patients and, for reasons mentioned above, determinations of the binding capacity of tumours from pre-and postmenopausal patients are not directly comparable.
LS B-protein was not detectable in human mammary tumours. This is in agreement with our previous investigations of murine mammary tumours (Schuilein et al., 1974) . However, the difference in LS A-protein activity in human tumours with high and low receptor content is not completely in agreement with our previous findings in GR mice. In GR mouse LS A-protein activity is high in both hormone dependent and independent tumours in spite of (lifferences in receptor content (Schiulein et al., 1974) . As already mentioned, animal experiments have shown G-6-PDH and LS to be hormone inducible. Whether this is also the case in women is not known. However, if this is so the high activities of G-6-PDH and LS-A found in the present study in tumours with high contents of oestradiol receptor protein indicate that the receptor protein in these tumours is functional at the oestrogen concentration present in the patients.
The reports by Jensen et al. (1973) and Engelsman et al. (1973) referred to above, suggest a correlation between the content of oestradiol receptor protein and hormone dependence in human mammary tumours.
A similar correlation with G-6-PDH and LS-A activities might possibly be expected. In order to clarify this possibility, we have started a controlled clinical study of the correlation between the biochemical parameters discussed in the present communication and the response of primary humani mammary cancer to oestrogen and anti-oestrogen treatment.
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